Levetiractam intermediates
[Cas no.: 102849-49-0]
(2S)-2-(2-oxopyrrolidin-1-yl)-butanoic acid
Levoceterizine intermediates
4-Chlorophenzhydrylamine HCL
(-)-1-[1-(4-Chlorophenyl)phenylmethyl]piperazine [130018-88-1]
(-)-1-[1-(4-Chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl]piperazine[163837-56-7]
Levosimendan intermediates
[Cas no.: 101328-85-2]
(R)-6-(4-Aminophenyl)-5-Methylpyridazin-3(2h)One
Levosulpiride intermediates
Levorotatory-N-ethyl-2-Aminomethyl-pyrrolidine
Lisinopril intermediates
N2-1[(1s)- ethoxycarbonyl-3-phenypropy]- N6-Trifluoroacetyl-L-Lysine
1-[N2-1[(1S)-ethoxycarbonyl-3-phenypropy]- N6-Trifluoroacetyl-L-Lysyl-L-Proline
Loratadine intermediates
2-Cyano-3-Methylpyridine 99% min.
3-[2-(3-Chlorophenyl)Ethyl]-2-Pyridine-Carbonitrile
8-Chloro-5, 6-Dihydro-11h-Benzo-[5, 6]-Cyclohepta -[1, 2, B] Pyridin-11-One
8-Chloro-6, 11-Dihydro-11-(1-Methyl Piperidiry)-5h-Benzo[5, 6]-Cyclohepta[1, 2, B]
Pyridine
Losartan intermediates
2-Butyl-5-Chloro-1H-Imidazole-4-Carboxaldehyde 99% min.
Triphenyl Losartan 99% min.
N-(Triphenylmethyl)-5-(4'-methylbiphenyl-2-yl-)tetrazole 98.5% min.
Loxapine/Amoxapine intermediates
2-Chloro-10, 11-dihydro-11-oxo-dibenz[b, f][1, 4]oxazepine 98%. 5% min.
Manidipine HCL intermediates
[Cas no.: 74936-72-4]
1, 4-Dihydro-2, 6-Dimethyl-4-(3-Nitrophenyl)-3, 5-pyridinedicarboxylic acid
Monomethylester
Mirtazapine intermediates
1-Methyl-3-Phenyl piperazine
1-(3-Hydroxymethylpyridine-2-)-2-phenyl-4-methyl piperazine
Moxifloxacin intermediates
(S, S)-2, 8-Diazabicyclo[4, 3, 0]nonane
Moxonidine intermediates
5-Amino-4, 6-Dichloro-2-Methyl Pyrimidine
Nadifloxacin intermediates
[Cas no.: 80076-47-7]
(α )-8, 9-difluoro-5-methyl-6, 7-dihydro-1-oxo-1H, 5H-benzo[i, j]quinolizine-2-carboxylic acid
Nebivolol intermediates
[Cas no.: 99199-59-4]
6-Fluoro-4-Oxo-4H-Chromene-2-Carboxylic acid
Nefazodone intermediates
1-[(3-Chlorophenyl)-4-chloropropyl]piperazine
Olmesartan intermediates
[Cas no.: 144690-92-6]
N-Triphenyl methyl Olmesartan
Omeprazole intermediates
2, 3, 5-Trimethyl pyridine
2-Mercapto-5-Methoxy benzimidazole
3, 5-Dimethyl-4-Nitro-2-Hydroxymethyl Pyridine
3, 5-Dimethyl-2-Hydroxymethyl-4-Methoxy Pyridine
2-Chloromethyl-3.5-dimethyl-4-methoxypyridine HCL
Olanzepine intermediates
2-Amino-3-Cyano-5-methyl thiophene
4-Amino-2-Methyl-10h-Thieno[2, 3-B][1, 5]Benzodiazepine HCL Cas no.: [138564-60-0]
Ozagrel intermediates
Methyl-T-bromomethyl cinnamate
Oxcarbazepine intermediates
5-Cyano-5h-Dibenzo(B, F) Azepine
10-Methoxyl Iminostilbene
Visen Pharmaceutical's a young, dynamic growing company. We specialize in the marketing of pharmaceutical raw materials, intermediates, plant extracts, food & feed additive, dyestuff, agrochemicals, etc.
We are capable of developing new products according to customer's requirements and making contracted manufacturing under confidential agreement with customers. The whole process is strictly complying with GMP requirements and under QA system.
We committed to ensure that every product manufactured and distributed meets with internationally accepted standards of quality and safety.
